Cullinan Therapeutics (CGEM) vs Odyssey Therapeutics (ODTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cullinan Therapeutics is the larger company by market cap ($960.6 million vs $868.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CGEM | ODTX |
|---|---|---|
| Share price | $15.63 | $18.08 |
| Market cap | $960.59M | $868.90M |
| 1-day change | -3.82% | -0.28% |
| YTD return | +51.01% | — |
| 1-year return | +165.37% | — |
| 5-year return | -37.48% | — |
| EPS (TTM) | $-3.11 | $-7.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.19 | $29.05 |
| 52-week low | $5.85 | $15.10 |
| Distance from 52-week high | -32.60% | -37.76% |
| Average volume | 868.12K | 271.56K |
| Shares outstanding | 61.46M | 48.06M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CGEM vs ODTX FAQ
Which is bigger, Cullinan Therapeutics or Odyssey Therapeutics?
Cullinan Therapeutics (CGEM) is larger, with a market capitalization of $960.59M compared with $868.90M for Odyssey Therapeutics (ODTX).
Are Cullinan Therapeutics and Odyssey Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.